Format
Sort by
Items per page

Send to

Choose Destination

Best matches for primary lateral sclerosis:

Primary Lateral Sclerosis. Statland JM et al. Neurol Clin. (2015)

The concept and diagnostic criteria of primary lateral sclerosis. Wais V et al. Acta Neurol Scand. (2017)

Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Grad LI et al. Cold Spring Harb Perspect Med. (2017)

Search results

Items: 1 to 20 of 31424

1.

In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis.

Bonifacino T, Provenzano F, Gallia E, Ravera S, Torazza C, Bossi S, Ferrando S, Puliti A, Van Den Bosch L, Bonanno G, Milanese M.

Neurobiol Dis. 2019 May 15. pii: S0969-9961(19)30121-4. doi: 10.1016/j.nbd.2019.05.007. [Epub ahead of print]

PMID:
31102766
2.

Biallelic variant in AGTPBP1 causes infantile lower motor neuron degeneration and cerebellar atrophy.

Karakaya M, Paketci C, Altmueller J, Thiele H, Hoelker I, Yis U, Wirth B.

Am J Med Genet A. 2019 May 18. doi: 10.1002/ajmg.a.61198. [Epub ahead of print]

PMID:
31102495
3.

The Protective Effects of Levetiracetam on a Human iPSCs-Derived Spinal Muscular Atrophy Model.

Ando S, Funato M, Ohuchi K, Inagaki S, Sato A, Seki J, Kawase C, Saito T, Nishio H, Nakamura S, Shimazawa M, Kaneko H, Hara H.

Neurochem Res. 2019 May 17. doi: 10.1007/s11064-019-02814-4. [Epub ahead of print]

PMID:
31102025
4.

Factors that predict diagnostic stability in neurodegenerative dementia.

Perry DC, Datta S, Miller ZA, Rankin KP, Gorno-Tempini ML, Kramer JH, Rosen HJ, Seeley WW, Miller BL.

J Neurol. 2019 May 17. doi: 10.1007/s00415-019-09362-5. [Epub ahead of print]

PMID:
31102021
5.

Is the evidence strong enough for acupuncture ameliorates clinical symptoms in patients with amyotrophic lateral sclerosis: A protocol for a systematic review and meta-analysis.

Liao Q, Li Z, Zeng H, Feng X, Huang W, Fu C, Liang X, Li T.

Medicine (Baltimore). 2019 May;98(20):e15218. doi: 10.1097/MD.0000000000015218.

6.

Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy.

Neil EE, Bisaccia EK.

J Pediatr Pharmacol Ther. 2019 May-Jun;24(3):194-203. doi: 10.5863/1551-6776-24.3.194. Review.

7.

The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing.

Tischbein M, Baron DM, Lin YC, Gall KV, Landers JE, Fallini C, Bosco DA.

J Biol Chem. 2019 May 15. pii: jbc.RA118.005933. doi: 10.1074/jbc.RA118.005933. [Epub ahead of print]

8.

Loss of Cajal bodies in motor neurons from patients with novel mutations in VRK1.

El-Bazzal L, Rihan K, Bernard-Marissal N, Castro C, Chouery-Khoury E, Desvignes JP, Atkinson A, Bertaux K, Koussa S, Lévy N, Bartoli M, Mégarbané A, Jabbour R, Delague V.

Hum Mol Genet. 2019 Apr 2. pii: ddz060. doi: 10.1093/hmg/ddz060. [Epub ahead of print]

PMID:
31090908
9.

Amyotrophic lateral sclerosis type 8 is not a pure motor disease: evidence from a neuropsychological and behavioural study.

de Alcântara C, Cruzeiro MM, França MC Jr, Camargos ST, de Souza LC.

J Neurol. 2019 May 14. doi: 10.1007/s00415-019-09369-y. [Epub ahead of print]

PMID:
31089860
10.

Genomic mosaicism: A neglected factor that promotes variability in asthma diagnosis.

de Bittencourt Buss T, Mroginski L, de Jesus GM, Forcellini S, Didoné AVL, Mayer FQ, Vargas JE.

Med Hypotheses. 2019 Jun;127:112-115. doi: 10.1016/j.mehy.2019.04.009. Epub 2019 Apr 13.

PMID:
31088633
11.

A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction.

Afshar Bakooshli M, Lippmann ES, Mulcahy B, Iyer N, Nguyen CT, Tung K, Stewart BA, van den Dorpel H, Fuehrmann T, Shoichet M, Bigot A, Pegoraro E, Ahn H, Ginsberg H, Zhen M, Ashton RS, Gilbert PM.

Elife. 2019 May 14;8. pii: e44530. doi: 10.7554/eLife.44530.

12.

Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review.

Howard I.

J Palliat Med. 2019 May 14. doi: 10.1089/jpm.2018.0531. [Epub ahead of print]

PMID:
31084461
13.

A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis.

Shefner JM, Cudkowicz ME, Hardiman O, Cockroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff AA, Andrews JA; VITALITY-ALS STUDY GROUP.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May 13:1-9. doi: 10.1080/21678421.2019.1612922. [Epub ahead of print]

PMID:
31081694
14.

Modeling Motor Neuron Resilience in ALS Using Stem Cells.

Allodi I, Nijssen J, Benitez JA, Schweingruber C, Fuchs A, Bonvicini G, Cao M, Kiehn O, Hedlund E.

Stem Cell Reports. 2019 Apr 23. pii: S2213-6711(19)30131-6. doi: 10.1016/j.stemcr.2019.04.009. [Epub ahead of print]

15.

Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.

Kishimoto Y, Zhu W, Hosoda W, Sen JM, Mattson MP.

Neuromolecular Med. 2019 May 11. doi: 10.1007/s12017-019-08539-5. [Epub ahead of print]

PMID:
31079293
16.

Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.

Mishra A, Singh S, Tiwari V, Chaturvedi S, Wahajuddin M, Shukla S.

Neurochem Int. 2019 May 9:104463. doi: 10.1016/j.neuint.2019.104463. [Epub ahead of print]

PMID:
31078578
17.

Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease.

Jahnová H, Poupětová H, Jirečková J, Vlášková H, Košťálová E, Mazanec R, Zumrová A, Mečíř P, Mušová Z, Magner M.

J Neurol. 2019 May 10. doi: 10.1007/s00415-019-09364-3. [Epub ahead of print]

PMID:
31076878
18.

The microRNA miR-375-3p and the Tumor Suppressor NDRG2 are Involved in Sporadic Amyotrophic Lateral Sclerosis.

Rohm M, May C, Marcus K, Steinbach S, Theis V, Theiss C, Matschke V.

Cell Physiol Biochem. 2019;52(6):1412-1426. doi: 10.33594/000000099.

19.

Intact single muscle fibres from SOD1G93A ALS mice display preserved specific force, fatigue resistance, and training-like adaptations.

Cheng AJ, Allodi I, Chaillou T, Schlittler M, Ivarsson N, Lanner JT, Thams S, Hedlund E, Andersson DC.

J Physiol. 2019 May 9. doi: 10.1113/JP277456. [Epub ahead of print]

PMID:
31074054
20.

Therapeutic non-invasive brain stimulation in amyotrophic lateral sclerosis: rationale, methods and experience.

Edmond EC, Stagg CJ, Turner MR.

J Neurol Neurosurg Psychiatry. 2019 May 9. pii: jnnp-2018-320213. doi: 10.1136/jnnp-2018-320213. [Epub ahead of print] Review.

PMID:
31072957

Supplemental Content

Loading ...
Support Center